BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 18228271)

  • 1. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
    McCarron PA; Marouf WM; Donnelly RF; Scott C
    J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification.
    Weiss B; Schneider M; Muys L; Taetz S; Neumann D; Schaefer UF; Lehr CM
    Bioconjug Chem; 2007; 18(4):1087-94. PubMed ID: 17590034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
    Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL
    Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
    Yin Y; Chen D; Qiao M; Lu Z; Hu H
    J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.
    Choi SW; Kim JH
    J Control Release; 2007 Sep; 122(1):24-30. PubMed ID: 17628158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system.
    Gao H; Wang YN; Fan YG; Ma JB
    J Biomed Mater Res A; 2007 Jan; 80(1):111-22. PubMed ID: 16960831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
    Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
    J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
    Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells.
    McCarron PA; Marouf WM; Quinn DJ; Fay F; Burden RE; Olwill SA; Scott CJ
    Bioconjug Chem; 2008 Aug; 19(8):1561-9. PubMed ID: 18627195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
    Kim DH; Martin DC
    Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
    Nie H; Wang CH
    J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation.
    Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS
    J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Composites of poly(lactide-co-glycolide) and the surface modified carbonated hydroxyapatite nanoparticles.
    Hong Z; Zhang P; Liu A; Chen L; Chen X; Jing X
    J Biomed Mater Res A; 2007 Jun; 81(3):515-22. PubMed ID: 17133447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.